Elderly patients in chronic hemodialysis: Risk factors for left ventricular hypertrophy

American Journal of Kidney Diseases

Volumn 30, Issue 2, 1997, Pages 224-228

  Neves, Pedro Leão ^a   Silva, Ana Paula ^a   Bernardo, Idalécio ^a  

^a HOSPITAL DE FARO   (Portugal)

Author keywords

Chronic hemodialysis; Elderly; Left ventricular hypertrophy

Indexed keywords

AGED; AGING; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; DATA ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; SUBSTITUTION THERAPY; SYSTOLIC BLOOD PRESSURE;

EID: 0030805522     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90056-1     Document Type: Article

References (28)

1. Wing AJ, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood N, Gretz N: Cardiovascular-related causes of death and the fate of patients with renovascular disease. Contrib Nephrol 41:306-311, 1984
2. Brunner FP, Selwood N, on behalf of the EDTA Registration Committee: Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int 42:S4-S11, 1992 (suppl 38)
3. Kannel WB, Gordon T, Offut D: Left ventricular hypertrophy by electrocardiogram: Prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 71:89-105, 1969
4. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
5. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE: The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 55:114-120, 1990
6. Eggers PW: Heath care policies/economics of the geriatric renal population. Am J Kidney Dis 16:384-391, 1990
7. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrábano F: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7:7-35, 1992 (suppl 2)
8. Neves PL: Chronic haemodialysis in elderly patients. Nephrol Dial Transplant 10:69-71, 1995 (suppl 6)
9. Devereaux RB, Reicher N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618, 1977
10. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barri PE: Congestive heart failure in dialysis patients. Arch Intern Med 148:1519-1525, 1988
11. Harnett JD, Foley RN, Kent GM, Barri PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
12. USRDS 1990 Annual Report: The demographics of ESRD. Am J Kidney Dis 16:28-33, 1990 (suppl 2)
13. USRDS 1994 Annual Data Report: Incidence and Causes of Treated ESRD. Am J Kidney Dis 24:S48-S56, 1994 (suppl 2)
14. Zuchelli P, Santoro A, Zuccala A: Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 8:163-188, 1988
15. Churchill DN: Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients. Kidney Int 43:S16-S22, 1993 (suppl 40)
16. Harnett JD, Kent GM, Foley RN, Parfrey PS: Cardiac function and hematocrit level. Am J Kidney Dis 25:S3-S7, 1995 (suppl 1)
17. Ruzicka M, Leenen FHH: Hypertensive therapy in dialysis patients. Semin Dial 3:176-178, 1994
18. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN: Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 24:768-776, 1994
19. Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey P: The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 65:212-214, 1993
20. Silberberg JS, Racine N, Barre PE, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6:1-4, 1990
21. Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J: Regression of let ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study. Clin Nephrol 35:280-287, 1991
22. Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA: Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 19:353-357, 1992
23. Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W: Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic haemodialysis patients. Am J Nephrol 11:54-60, 1991
24. Onoyama K, Hori K, Osata S, Fujishima M: Haemodynamic effect of recombinant human erythropoietin on hypotensive haemodialysis patients. Nephrol Dial Transplant 6:562-565, 1991
25. Maschio G: Erythropoietin and systemic hypertension. Nephrol Dial Transplant 10:74-79, 1995 (suppl 2)
26. Grossman E, Alster Y, Shemesh J, Nussinovitch N, Rosenthal T: Left ventricular mass in hypertension. Correlation with casual, exercise and ambulatory blood pressure. J Hum Hypertens 8:741-746, 1994
27. Rodby RA, Vonesh EF, Korbet SM: Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring. Am J Kidney Dis 23:401-411, 1994
28. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4:1486-1490, 1994